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a-Mangostin is the major prenylated xanthone from Garcinia mangostana and it has
been used also in recent times as starting material for the semisynthetic preparation of
various biologically active derivatives. Its structure is characterised by the presence of
few functional groups amenable to chemical manipulations, but present in the molecule
in multiple instances (three phenolic hydroxyl groups, two prenyl chains and two
unsubstituted aromatic carbons). This study represents a first approach to the
systematic investigation of the reactivity of a-mangostin and describes the semis-
ynthesis of some minor xanthones isolated from G. mangostana.
Keywords: a-mangostin; Garcinia mangostana; semisynthesis; acid-catalysed cycli-
sation; oxidative cyclisation
1. Introduction
a-, b- and g-Mangostin (1, 2 and 3, Figure 1) represent the most abundant prenylated xanthones
in Garcinia mangostana L. (Guttiferae) (Obolskiy et al. 2009), and several biological activities
have been ascribed to the former (Larson et al. 2010; Krajarng et al. 2011; Quan et al. 2012;
Wang et al. 2012; Koh et al. 2013). However, interesting biological properties have been
attributed also to some minor components of the plant (Ho et al. 2002; Suksamrarn et al. 2003;
Jung et al. 2006; Suksamrarn et al. 2006). Among these, 9-hydroxycalabaxanthone (11, Figure 1)
showed cytotoxic activity towards HT-29 human colon cancer cell line (Han et al. 2009) and a
moderate inhibitory activity towards neuraminidase (Ryu et al. 2010). Also 3-isomangostin (14,
Figure 1) has cytotoxic activity (Han et al. 2009) and it is an inhibitor of mammalian DNA
polymerases (Mizushina et al. 2013) and a selective inhibitor of acetylcholinesterase (Khaw
et al. 2014). Its hydrate form 16 is an inhibitor of the catalytic subunit of cyclic AMP-dependent
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protein kinase (Lu et al. 1998). Mangostanin (12, Figure 1) showed cancer chemopreventive
properties due to a quinone reductase-inducing activity comparable to that of liquiritigenin used
as the positive control (Chin et al. 2008). Some of these studies give, however, an incomplete
description of the biological activities, due often to the insufficient amounts of material obtained
from the plant. Difficulties in the isolation of such minor constituents led to the development of
semisynthetic analogues (see for example Ren et al. 2011; Keiser et al. 2012; Sudta et al. 2013;
Zou et al. 2013; Fei et al. 2014). Chemical modification of a-mangostin is a matter of selectivity,
in that it possesses more than one instance of otherwise few types of functional groups (phenolic
hydroxyls, prenyl chains and unsubstituted aromatic carbons) (Figure 1). Even if the chemical
behaviour of a-mangostin can emerge through the comparison of already published results, a
comprehensive and not fragmentary analysis of its reactivity is lacking. This paper describes the
first systematic approach to the manipulation of functional groups of a-mangostin, in the search
for reaction conditions aimed at the preparation of minor xanthones of G. mangostana using the
most abundant component a-mangostin as the starting material.
2. Results and discussion
2.1. Reactivity of the hydroxyl groups of a-mangostin
The acetylation reactions of the phenolic hydroxyl groups of a-mangostin have been already
reported both as a tool for structure elucidation (Jefferson et al. 1970) and in the search for
biologically active derivatives (recent examples: Ren et al. 2011; Keiser et al. 2012; Sudta et al.
2013; Fei et al. 2014). The most accessible phenolic hydroxyl groups are those in positions 3 and
Figure 1. Prenylated xanthones from G. mangostana (1–3 and 11–16) and synthetic derivatives of a-
mangostin.
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6, while the hydroxyl group in 1 hardly reacts (Ren et al. 2011), probably due to its involvement
in an intramolecular hydrogen bond with the carbonyl oxygen in position 9.
Using 1 equiv. of acetic anhydride in the presence of triethylamine at low temperature, the
3,6-diacetyl derivative 4 (Table 1, entry 1) and the monoacetyl derivative 5 were obtained in
nearly equal molar amount. The preferential acetylation of the 6-hydroxyl group with respect to
that in position 3 is a recurrent motif in the chemistry of a-mangostin (Sudta et al. 2013; Fei et al.
2014), and it was noticed also using benzoyl chloride as the acylating agent (Table 1, entry 4)
and in the methylation reaction with methyl iodide (Table 1, entry 5).
Using the mild acetylating agent N-acetylimidazole, the 3-acetyl derivative 6 was obtained
as the main product (Table 1, entry 2). This result is the opposite with respect to that observed
previously and to the best of our knowledge it was never reported before. The different
regioselectivity could be ascribed to the increased reactivity of the protonated form of N-
acetylimidazole towards the transfer of the acetyl group (Fife 1993). Although no reports exist
about the different acidities of the phenolic hydroxyl groups of a-mangostin, we hypothesise that
the imidazole ring could abstract a proton preferentially from the 3-phenolic hydroxyl, affording
both a more powerful acetylating agent (the protonated form of N-acetylimidazole) and the more
nucleophilic phenolate anion.
2.2. Reactions involving the prenyl groups of a-mangostin
Several xanthones from G. mangostana have one or more additional oxygenated ring,
originating from reactions involving prenyl and phenolic hydroxyl groups through oxidative
cyclisations (e.g. 9-hydroxycalabaxanthone 11 and mangostanin 12) or addition reactions, e.g. 1-
isomangostin 13 and 3-isomangostin 14.
By reacting a-mangostin with DDQ, 9-hydroxycalabaxanthone 11, also known as
garciniafuran (Nilar & Harrison 2002), was obtained in 70% yield. In the meantime the same
approach was reported by Dharmaratne et al. (2013).
Mangostanin 12, a furanoxanthone from the heartwood of G. mangostana (Nilar & Harrison
2002), could originate from the putative epoxide intermediate 17 through attack of the 3-
phenolic oxygen on the less substituted carbon atom of the oxirane ring (Figure 2). The reaction
is enzymatically controlled, as the stereocentre has (R) configuration (Han et al. 2009). Using a
Table 1. Acylation and alkylation reactions of the hydroxyl groups of a-mangostin.
Entry Conditions Product(s) (%)
1 Ac2O (1.1 equiv.), Et3N (4 equiv.), CH2Cl2, 08C 4 (30); 5 (33)
2 N-Acetylimidazole (2 equiv.), CH2Cl2, rt 4 (8); 6 (44)
3 Ac2O (4 equiv.), Et3N (4 equiv.), toluene, rt 4 (99)
4 Benzoyl chloride (1.1 equiv.), Et3N (4 equiv.), CH2Cl2, 08C 7 (39); 8 (36)
5 MeI (18 equiv.), NaHCO3 (4.5 equiv.), DMF, rt 9 (29); 10 (51)
Figure 2. Proposed biosynthetic route and biomimetic approach to mangostanin 12.
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biomimetic approach, racemic mangostanin 12 was obtained in 25% yield by reacting a-
mangostin with m-chloroperbenzoic acid, and up to 46% yield when oxonew was used as the
oxidising agent in a biphasic system.
1- and 3-Isomangostin (13, 14) and their hydrate forms 15 and 16 were isolated from
G. mangostana in 1987 (Mahabusarakam et al. 1987), but some of them were already known
synthetic compounds (Yates & Bath 1970). As the prenyl group in position 2 is flanked by two
phenolic hydroxyls, both intermediates 18A and 18B could be formed (Figure 3). Due to the
carbocationic character of 18A and 18B, nucleophilic attack of the phenolic oxygen atom occurs
at the tertiary carbon, leading to the six-membered pyranose derivatives 13 and 14.
Depending on the reaction conditions, the corresponding hydrated derivatives 15 and 16
could also be obtained. By reacting a-mangostin with a catalytic amount of p-toluenesulphonic
acid, the four compounds 13–16 were isolated (Table 2, entry 1). In an attempt to reduce the
complexity of the reaction mixture, several different acid/solvent systems were tested. With the
dehydrating sulphuric acid in toluene in the presence of molecular sieves at 408C, 1-
isomangostin hydrate 15 was the main product together with minor amounts of 3-isomangostin
14 (Table 2, entry 3). The latter was the only isolated product at lower temperature and in the
presence of a catalytic amount of acid, albeit the conversion of the starting material was low
(Table 2, entry 2). Using the Lewis acid BF3 in anhydrous conditions, 1-isomangostin 13 was
isolated in 29% yield (Table 2, entry 4). In the light of these results, we tried the use of the protic
trifluoroacetic acid in anhydrous conditions (Table 2, entry 5). The trifluoroacetyl derivatives of
1-isomangostin hydrate 19 and 18-O-trifluoroacetyl-3-isomangostin hydrate 20 were isolated in
25% and 56% yield, respectively, with complete conversion of the starting material.
3. Conclusions
Our results constitute the first attempt to give a comprehensive and systematic picture of the
chemical behaviour of a-mangostin. Among the obtained results, the different reactivity of the
Figure 3. Hypotetical intermediates in the synthesis of isomangostins.
Table 2. Acid-catalysed and acid-promoted cyclisation reactions of a-mangostin.
Entry Acid (equiv.) Reaction conditions Product(s) (%)
1 p-TsOH (cat) Toluene/CH2Cl2 2:1, rt 13 (27), 14 (15), 15 (9), 16 (15)
2 H2SO4 (0.2)
a Toluene, rt 14 (20)b
3 H2SO4 (1)
a Toluene, 408C 14 (30), 15 (63)
4 BF3
. Et2O (cat) CH2Cl2, 08C to rt 13 (29), 15 (9)
5 CF3COOH (1) CH2Cl2, rt 19 (25), 20 (56)
aMolecular sieves of 4 A˚ were added to the reaction mixture.
b Seventy-four percent of unreacted a-mangostin was recovered.
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phenolic hydroxyl groups in 3 and 6 positions, depending on the experimental conditions (acetic
anhydride vs N-acetylimidazole), could be of interest for a temporary selective protection of one
of them. Both oxidative and non-oxidative cyclisation reactions involving the 2-prenyl group
could represent an alternative entry to the minor xanthones from G. mangostana with respect to
cumbersome and low-yielding extractive procedures, in view of detailed biological studies
requiring some amount of material.
Supplementary material
Experimental details relating to this article are available online.
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